Answers are grounded in this paper and cite their sources.
Combination of plasma Abeta(1-42/1-40) and GFAP provides a valuable tool for the identification of amyloid PET status. Furthermore, plasma GFAP and NfL associate with various disease severity measures suggesting potential for disease monitoring.
No takes yet. Share an insight, caveat, or question.
Verberk et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: